Hughes Owen

Director at C4 Therapeutics, Inc. · on record since Nov 20, 2023
Chief Executive Officer at XOMA Royalty Corp · on record since Jan 6, 2023
Director at XOMA Royalty Corp · on record since Apr 22, 2026
Director at ANAPTYSBIO, INC · on record since May 13, 2026
Director at Radius Health, Inc. · on record since May 3, 2013
Director at Translate Bio, Inc. · on record since Jun 27, 2018
Director at PARDES BIOSCIENCES, INC. · on record since Feb 16, 2021
Director at Cullinan Therapeutics, Inc. · on record since Jan 14, 2021
President and CEO at Cullinan Therapeutics, Inc. · on record since Jan 14, 2021
Director at ImageneBio, Inc. · on record since Dec 19, 2022

Insider trading activity of Hughes Owen

Transactions on record: 75; since Jun 9, 2014

Open-market buys: 8; $2.7M

Open-market sells: 5; $2.5M

Companies traded: 8; last filing Jul 14, 2026

Figures computed from official regulatory filings — .

Companies where Hughes Owen has traded

XOMA Royalty Corp29 tx · $3.9M · Jul 14, 2026
C4 Therapeutics, Inc.4 tx · Jun 26, 2026
ANAPTYSBIO, INC1 tx · May 13, 2026
ImageneBio, Inc.3 tx · Jun 10, 2024
Radius Health, Inc.24 tx · $421K · Aug 15, 2022
PARDES BIOSCIENCES, INC.4 tx · Dec 30, 2021
8 tx · $1.1M · Sep 14, 2021
2 tx · $52.5K · Jan 14, 2021

Track record of Hughes Owen

Statistical track record

Free account

Open-market buys: 8

Last buy: Dec 4, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Hughes Owen

Co-insiders of Hughes Owen

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-132,714	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-116,245	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-191,264	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-102,000	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-752	—	n/a (No price was disclosed in the filing)		SEC
C4 Therapeutics, Inc.Listing on record	Jun 26, 2026	AwardD (derivative)	62,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ANAPTYSBIO, INCListing on record	May 13, 2026	AwardD (derivative)	11,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Apr 22, 2026	ExerciseD (derivative)	-10,568	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Apr 22, 2026	Exercise	10,568	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Mar 17, 2026	AwardD (derivative)	126,813	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Mar 17, 2026	Award	82,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Dec 8, 2025	Buy	100,000	25.05 USD	$2.5M	conv 81Unusual sizeFirst in 12mo	SEC
XOMA Royalty CorpSecurity delisted	Sep 23, 2025	Exercise	35,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Sep 23, 2025	ExerciseD (derivative)	-35,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
C4 Therapeutics, Inc.Listing on record	Jun 20, 2025	AwardD (derivative)	35,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	Sell	-25,637	25.38 USD	$650.7K		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	ExerciseD (derivative)	-53,359	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	Exercise	53,359	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	Sell	-21,881	29.95 USD	$655.3K		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	ExerciseD (derivative)	-53,360	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	Exercise	53,360	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
C4 Therapeutics, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-132,714	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-116,245	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-191,264	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-102,000	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	OtherD (derivative)	-75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 14, 2026	Other	-752	—	n/a (No price was disclosed in the filing)		SEC
C4 Therapeutics, Inc.Listing on record	Jun 26, 2026	AwardD (derivative)	62,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ANAPTYSBIO, INCListing on record	May 13, 2026	AwardD (derivative)	11,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Apr 22, 2026	ExerciseD (derivative)	-10,568	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Apr 22, 2026	Exercise	10,568	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Mar 17, 2026	AwardD (derivative)	126,813	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Mar 17, 2026	Award	82,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Dec 8, 2025	Buy	100,000	25.05 USD	$2.5M	conv 81Unusual sizeFirst in 12mo	SEC
XOMA Royalty CorpSecurity delisted	Sep 23, 2025	Exercise	35,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Sep 23, 2025	ExerciseD (derivative)	-35,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
C4 Therapeutics, Inc.Listing on record	Jun 20, 2025	AwardD (derivative)	35,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	Sell	-25,637	25.38 USD	$650.7K		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	ExerciseD (derivative)	-53,359	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 21, 2025	Exercise	53,359	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	Sell	-21,881	29.95 USD	$655.3K		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	ExerciseD (derivative)	-53,360	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Nov 13, 2024	Exercise	53,360	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
C4 Therapeutics, Inc.Listing on record	Jun 21, 2024	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ImageneBio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	17,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC